跳至主要内容
临床试验/NCT01532180
NCT01532180已完成不适用

A Pilot Study and Follow Up of the Use of a Hypoglossal Nerve Implant for Treatment of Obstructive Sleep Apnea

ImThera Medical, Inc.2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2009年11月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
2
主要终点
Adverse events and Serious Adverse events peri and post-operatively

研究概览

简要总结

The objective of the study is to determine the safety and preliminary efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate to severe obstructive sleep apnea (AHI 15 to 60).
  • Cannot or will not tolerate CPAP treatment.
  • Body mass index (BMI) between 25 and 40
  • Able to read, understand, sign and date the written informed consent form

排除标准

  • 未提供

研究组 & 干预措施

THN Therapy

Experimental

干预措施: aura6000 System (Device)

结局指标

主要结局

Adverse events and Serious Adverse events peri and post-operatively

时间窗: 3 and 12 months post-operative

Mean change in AHI measured through in-lab polysomnography (PSG) compared to baseline.

时间窗: 3 and 12 months post-implant

次要结局

  • Mean change in Quality of Life outcomes measured with FSS (Fatigue Severity Scale) as compared to baseline.(3 and 12 months post-implantation)
  • Mean change in Quality of Life outcomes measured with ESS (Epworth Sleepiness Scale) as compared to baseline.(3 and 12 months post-operative)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验